Cancer Epidemiology in Lahore, Pakistan - 2010-2015.


Journal

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
ISSN: 1681-7168
Titre abrégé: J Coll Physicians Surg Pak
Pays: Pakistan
ID NLM: 9606447

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 11 09 2019
accepted: 13 01 2020
entrez: 11 2 2020
pubmed: 11 2 2020
medline: 18 12 2020
Statut: ppublish

Résumé

To study the cancer incidence rates in Lahore, which has an estimated annual population count of 10.3 million. Cross-sectional study. Data on new cancer cases diagnosed between 2010 and 2015, among the residents of Lahore district, Pakistan, was reviewed retrospectively in 2015-2017. Nineteen collaborating centres of the population-based Punjab Cancer Registry (PCR), representing both the government and private sectors, reported their cases to the coordinating office located within the Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC). The age-standardised incidence rates (ASIR) per 100,000 population, over a six-year period, were computed. Sixteen 5-year age groups were created beginning from 0-4 to 70-74 years, followed by 75+ years. Graphs on the five-year age-specific incidence rates by gender, were also generated. Between 2010 and 2015, 33,028 new malignancies were recorded in Lahore, with the crude average annual incidence rate being 53.1. In adults, the highest ASIRs were noted for cancers of the breast (77.3) among females and of prostate (11.4) in men. Age-specific incidence rates for female breast cancer showed an upward trend at the age of 20 years, reaching a figure of 160 at the age of 55 years. Among males, the rates for prostate cancer started to increase at the age of 55 years and reached a peak of 93 at 75 years. These results warrant expanding cancer registration in the region and sharing statistics with policy-makers to establish hospitals accordingly to manage cancer, along with exploring various risk factors within the population.

Identifiants

pubmed: 32036815
pii: 040579197
doi: 10.29271/jcpsp.2020.02.113
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-122

Auteurs

Farhana Badar (F)

Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Shahid Mahmood (S)

Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Mohammad Tariq Mahmood (MT)

Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Misbah Masood (M)

Oncology Division, Institute of Nuclear Medicine and Oncology, Lahore, Pakistan.

Imrana Tanvir (I)

Department of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia.

Omar Rasheed Chughtai (OR)

Chughtai Lab, Lahore, Pakistan.

Shahida Niazi (S)

Department of Pathology, King Edward Medical University, Lahore, Pakistan.

Alia Ahmad (A)

Department of Pediatric Hematology/Oncology, The Children's Hospital and The Institute of Child Health, Lahore, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH